George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
There still remains risk in getting AVA6K to market.
The platform is risk free. Focus should be on the platform.
The completion of C7 and commentary on fair sides with enhanced efficacy is the biggest mover now. As PL states, FDA already point already known.
Given the patient pop within C7, this data is the stealth mover. And it should arrive in JAN. won’t move us massively, but should get us back to a less embarrassing base.
Thorn;
“ Because many/most/all of the current trial patients have been previously exposed to various chemotherapies and aren't treatment naive. I think Avacta have said that that's a thing, especially if there was previous Doxorubicin exposure.
May have got that wrong, in which case apologies.
Patients entering Phase 2 should be new diagnoses being randomly assigned to one of two arms (actually it might be 3 to allow different dosing regimes of AVA6000).
The behaviour and response might be different/better?
All appears to be going to plan though.”
That made no sense. Didn’t answer my question.
Again; Why should it be better???
Why should it be better Thorn?
Are you serious?
You said it Apre
Whatever you call it, they didn’t care what the cash was for. That was my point.
They spent the cash unwisely. IMO.
AVCT - we weren’t told what they were raising for. And why not? It was a loan shark - not an investor. They get paid every Q regardless
Not at all, an investor. Following my own lead. Have a try.
We’ve spent a horrendous amount of cash on a Dx box that’ll pay us nothing back for years. Cash that could have been spent progressing seriously valuable assets through the clinic. Money doesn’t grow on trees.
Or a better way, we can’t now progress parallel assets because we’ve waste the cash we had, on other things.
Commercialise something, then crack on. Until then, spend wisely.
I hope they partner/licence it. They haven’t got the cash to support another programme.
Not quite Timster. But there you go.
Thanks 13th. That supports the assertion that Albert is no better (worse than Ophidian). Cheers.
Thompi - thanks for the exchange, clearly you don’t take my slight on Albert personally. Odd that others do.
13th - post Albert’s response and view on the latest RNS on this thread.
Ok then - can you share Albert’s thoughts on the latest RNS? What’s his advice?
I understand the reasons for protecting Albert. And yes, I realise the TG group is at odds with Myles’s ramping.
But Albert categorically told the group to sell as news would take a while. Hence why so many of that group are now against Myles, no longer actively pushing it on Twitter, and very quiet until Albert pushes the next motivation.
All cool by the way, strategy is strategy. But don’t deny it.
Think you’re missing the point. Albert is worse than Ophidian. I’m not a fan of Ophidian, for the rumour crap in the main. But Albert actually told 100s in that group to sell the stock!!! It’s a cult, therefore assume they did.
Also charging for crayon lessons.
Fair enough Mark, but it’s true. Albert has sold and telling others to sell. Something you should research. Like is said, it’s very clear he has influence as none of the TG rampers have surfaced since he signalled. Not even a Stephen Casey high fiving little gunner.
Like I said, be careful slating this board and asserting that TG is more grown up. It isn’t. By definition it’s a clandestine group of people wanting a hug.
Morning Mark - you say that re discord; how do you explain Albert’s signal to sell to the very group AS trusted a meeting with? As in, he’s allegedly sold his stock and telling others to do the same?
Agree, this place is all but useless in the main - but the TG is not much better. Just acts more civilised when it’s actually more sly.
Exactly.